Groshar D, Moskovitz B, Gorenberg M, Frankel A, Jerusalmi J, Livne P M, Front D
Department of Nuclear Medicine, Rebecca Sieff Government Hospital, Safed, Israel.
J Nucl Med. 1994 Mar;35(3):445-9.
Quantitative SPECT was used to evaluate renal functional volume (cc), percent of injected dose/cc (%ID/cc) and renal uptake (%) in 11 children with unilateral vesicoureteral reflux grade 3 or greater, and in 19 normal control children without reflux.
Studies were performed 4-6 hr after intravenous injection of 0.750-2 mCi of 99mTc-DMSA.
Control kidneys (n = 38) had a volume of 99.7 +/- 29.5 cc. The %ID/cc was 0.27 +/- 0.08, and the uptake in one kidney was 24.8% +/- 3.9%. Global renal uptake (right plus left) was 49.6% +/- 7.3%. Functional volume of the control kidneys showed an increase with age, and the %ID/cc showed a steeper decrease with age, resulting in a trend of the kidney uptake to decrease with age. Kidneys with reflux had a decreased kidney uptake of 15.7% +/- 29.5%, compared to age- and sex-matched controls (t = 4.7, p < 0.001). The contralateral kidneys without reflux had a significantly increased total uptake of 33.4% +/- 6.8% as compared to controls (t = 3.44, p < 0.01). Global uptake by the kidneys was 49.2% +/- 8.6% and was not statistically different from controls (t = 1.0, ns).
Our results suggest that SPECT quantitation of 99mTc-DMSA uptake in each kidney separately could be used as a noninvasive method to assess impairment and compensation of the function of the individual kidney in children with vesicoureteral reflux.
采用定量单光子发射计算机断层扫描(SPECT)评估11例单侧膀胱输尿管反流3级及以上患儿和19例无反流的正常对照儿童的肾功体积(立方厘米)、每立方厘米注射剂量百分比(%ID/cc)及肾脏摄取率(%)。
静脉注射0.750 - 2毫居里的99m锝 - 二巯基丁二酸(99mTc - DMSA)后4 - 6小时进行检查。
对照肾脏(n = 38)体积为99.7±29.5立方厘米。每立方厘米注射剂量百分比为0.27±0.08,单个肾脏摄取率为24.8%±3.9%。双侧肾脏总体摄取率(右侧加左侧)为49.6%±7.3%。对照肾脏的功体积随年龄增加,每立方厘米注射剂量百分比随年龄下降更明显,导致肾脏摄取率有随年龄下降的趋势。与年龄和性别匹配的对照相比,有反流的肾脏摄取率降低至15.7%±29.5%(t = 4.7,p < 0.001)。无反流的对侧肾脏总摄取率较对照显著增加,为33.4%±6.8%(t = 3.44,p < 0.01)。肾脏总体摄取率为49.2%±8.6%,与对照无统计学差异(t = 1.0,无显著性差异)。
我们的结果表明,单独对每个肾脏的99mTc - DMSA摄取进行SPECT定量可作为一种非侵入性方法,用于评估膀胱输尿管反流患儿单个肾脏功能的损害和代偿情况。